First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence

Journal of Vascular Surgery: Venous and Lymphatic Disorders

Volumn 1, Issue 2, 2013, Pages 174-180

  Almeida, Jose I ^a   Javier, Julian J ^b   Mackay, Ed ^c   Bautista, Claudia ^d   Proebstle, Thomas M ^e  

^a Miami Vein Center   (United States)

^b Physician's Regional Medical Center   (United States)

^c Mackay Vein Institute   (United States)

^d Canela Clinic   (Dominican Republic)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHISTAMINIC AGENT; CYANOACRYLATE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; CELLULITIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; ENDOVASCULAR SURGERY; ERYTHEMA; FEASIBILITY STUDY; FEMALE; FEMORAL VEIN; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INTRAVENOUS CATHETER; LEG EDEMA; LEG VARICOSIS; MALE; PHLEBITIS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RECANALIZATION; SAFETY; SAPHENOUS VEIN; SCORING SYSTEM; SURGICAL TECHNIQUE; THROMBOPHLEBITIS; VEIN INSUFFICIENCY; VEIN OCCLUSION; VEIN THROMBOSIS;

EID: 84881267827     PISSN: 2213333X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvsv.2012.09.010     Document Type: Conference Paper

References (32)

1. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011;53:2-48S.
2. Proebstle TM, Gül D, Kargl A, Knop J. Non-occlusion and early reopening of the great saphenous vein after endovenous laser treatment is fluence dependent. Dermatol Surg 2004;30:174-8.
3. van den Bos R, Arendis L, Kockaert M, Neumann M, Nijsten T. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 2009;49:230-9.
4. Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg 2011;98:1079-87.
5. Almeida JI, Kaufmann J, Gockeritz O, Chopra P, Evans MT, Hoheim DF, et al. Radiofrequency Endovenous Closure FAST Versus Laser Ablation for the Treatment of Great Saphenous Vein Reflux: a multicenter, single-blinded, randomized study (RECOVERY Study). J Vasc Interv Radiol 2009;20:752-9.
6. Proebstle TM, Vago B, Alm J, Gockeritz O, Lebard C, Pichot O. Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience. J Vasc Surg 2008;47:151-6.
7. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31: 123-8.
8. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007;94: 925-36.
9. Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients. Phlebology 2009;34:131-8.
10. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-4.
11. Bush RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008;23:189-92.
12. Ma RW, Pilotelle A, Paraskevas P, Parsi K. Three cases of stroke following peripheral venous interventions. Phlebology 2011;26:280-4.
13. Linfante I, Wakhloo AK. Brain aneurysms and arteriovenous malformations: advancements and emerging treatments in endovascular embolization. Stroke 2007;38:1411-7.
14. Levrier O, Mekkaoui C, Rolland PH, Murphy K, Cabrol P, Moulin G, et al. Efficacy and low vascular toxicity of embolization with radical versus anionic polymerization of N-butyl-2-cyanoacrylate (NBCA): an experimental study in the swine. J Neuroradiol 2003;30:95-102.
15. Vinters HV, Galil KA, Lundie MJ, Kaufmann JC. The histotoxicity of cyanoacrylates: a selective review. J Neuroradiol 1985;27:279-91.
16. Spiegel SM, Vinuela F, Goldwasser JM, Fox AJ, Pelz DM. Adjusting the polymerization time of isobutyl-2 cyanoacrylate. Am J Neuroradiol 1986;7:109-12.
17. Min RJ, Almeida JI, McLean DJ, Madsen M, Raabe R. Novel vein closure procedure using a proprietary cyanoacrylate adhesive: 30-day swine model results. Phlebology 2012;27:398-403.
18. Almeida JI, Min RJ, Raabe R, McLean DJ, Madsen M. Cyanoacrylate adhesive for the closure of truncal veins: 60-day swine model results. Vasc Endovasc Surg 2011;45:631-5.
19. Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al; the American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248-52.
20. Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: a adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12.
21. Kakkos SK, Rivera MA, Matsagas MI, Lazarides MK, Robless P, Belcaro G, et al. Validation of the new venous severity scoring system in varicose vein surgery. J Vasc Surg 2004;39:696-7.
22. Merchant RF, DePalma RG, Kabnick LK. Endovascular obliteration of saphenous reflux: a multicenter study. J Vasc Surg 2002;35:1190-6.
23. Khilnani NM, Grassi CJ, Kundu S, D'Agostino HR, Khan AA, McGraw JK, et al. Multi-society consensus quality improvement guidelines for the treatment of lower extremity superficial venous insufficiency with endovenous thermal ablation from the Society of Interventional Radiology, Cardiovascular Interventional Radiological Society of Europe, American College of Phlebology, and Canadian Interventional Radiology Association. J Vasc Interv Radiol 2010;21: 14-31.
24. Kailasnath P, Chaloupka JC. Quantitative assessment of polymerization-binding mechanics of cyanoacrylates: model development and validation. Am J Neuroradiol 2002;23:772-8.
25. Gounis MJ, Leiber BB, Wakhloo AK, Siekmann R, Hopkins LN. Effect of glacial acetic acid and ethiodized oil concentration on embolization with N-butyl 2-cyanoacrylate: an in vivo investigation. Am J Neuroradiol 2002;23:938-44 21.
26. Aalto-Korte K, Alanko K, Kuuliala O, Jolanki R. Occupational methacrylate and acrylate allergy from glues. Contact Dermatitis 2008;58: 340-6.
27. Quinn JC, Mittal N, Baisre A, Cho ES, Sharer LR, Gandhi C, et al. Vascular inflammation with eosinophils after the use of n-butyl cyanoacrylate liquid embolic system. J Neurointerv Surg 2011;3:21-4.
28. Proebstle TM, Alm J, Göckeritz O, Wenzel C, Noppeney T, Lebard C, et al. European Closure Fast Clinical Study Group. Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities. J Vasc Surg 2011;54:146-52.
29. Min RJ, Zimmet SE, Isaacs MN, Forrestal MD. Endovenous laser treatment of the incompetent greater saphenous vein. J Vasc Interv Radiol 2001;12:1167-71.
30. Kabnick L. Outcome of different endovenous laser wavelengths for great saphenous vein ablation. J Vasc Surg 2006;43:88-93.
31. Houtermans-Auckel JP, van Rossum E, Teijink JA, Dahlmans AA, Eussen EF, Nicolaï SP, et al. To wear or not to wear compression stockings after varicose vein stripping: a randomised controlled trial. Eur J Vasc Endovasc Surg 2009;38:387-91.
32. Biswas S, Clark A, Shields DA. Randomised clinical trial of the duration of compression therapy after varicose vein surgery. Eur J Vasc Endovasc Surg 2007;33:631-7.